Cargando…
Boosting in the age of Omicron
A third dose of the inactivated vaccine CoronaVac fails to stimulate the production of neutralizing antibodies which target the Omicron variant.
Autor principal: | Sigal, Alex |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
eLife Sciences Publications, Ltd
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10110234/ https://www.ncbi.nlm.nih.gov/pubmed/37066867 http://dx.doi.org/10.7554/eLife.87358 |
Ejemplares similares
-
COVID-19 pandemic dynamics in South Africa and epidemiological characteristics of three variants of concern (Beta, Delta, and Omicron)
por: Yang, Wan, et al.
Publicado: (2022) -
An international observational study to assess the impact of the Omicron variant emergence on the clinical epidemiology of COVID-19 in hospitalised patients
por: Gonçalves, Bronner P, et al.
Publicado: (2022) -
Age, exposure and immunity
por: White, Michael, et al.
Publicado: (2018) -
The challenges of estimating biological age
por: Moskalev, Alexey
Publicado: (2020) -
Bone age is not just for kids
por: Cauley, Jane A, et al.
Publicado: (2021)